Co-Dx™ awarded $2.3M from Bill & Melinda Gates Foundation
Tuesday, July 18, 2023 1 min read
Key Takeaway: Co-Dx has been awarded $2.3 million in grants from the Bill & Melinda Gates Foundation. The funding includes $1.3 million for tuberculosis tests and $987,000 for HPV tests. These grants will help complete the tests for the Co-Dx PCR Home™ platform, targeting priority global markets.
Price reaction · baseline $40.5 (2023-07-17 close) · hit pre-market · 1 other CODX headline(s) in the window, move may be shared
day 0 close · peak
+4.4%
Market Sentiment Analysis
POSITIVE FACTORS
Co-Dx received significant funding from a reputable foundation.
The grants will support critical health tests for tuberculosis and HPV.
The funding is aimed at priority global markets, enhancing accessibility.
Full Press Release Details
In July 2023, Co-Dx was awarded two grants from the Bill & Melinda Gates Foundation totaling $2.3 million for its tuberculosis (TB) and human papillomavirus (HPV) tests.
The $1.3 million grant for tuberculosis and $987,000 grant for HPV will be applied toward completing the tests for the Co-Dx PCR Home™ platform, which are intended for priority global markets.